Ultimele actualizari :
05/12/2025
Antihistaminic H1   Cyclizine lactate  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf
   Formula chimica  

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cyclizine lactate Marea Britanie
Valoid Marea Britanie
Bibliografie   Injectabil   Bibliografie : Cyclizine lactate  
tip publicare
58 ziar Parker WA.
Physical compatibility of ranitidine HCl with preoperative injectable medications.
Can J Hosp Pharm 1985 ; 38: 160-161.
227 ziar Fawcett JP, Woods DJ, Munasiri B, Becket G.
Compatibility of cyclizine lactate and haloperidol lactate.
Am J Hosp Pharm 1994 ; 51: 2292.
788 ziar Regnard CFB, Mannix K.
Subcutaneous drug compatibility in palliative care.
Lancet 1989 ; 2 (8670): 1044-1045.
1230 ziar Regnard C, Pashley S, Westrope F.
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Br J Pharm Pract 1986 ; 8: 218-220.
1886 ziar Allwood MC.
The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes.
Palliative Med 1991 ; 5: 330-333.
2125 ziar Gardiner PR.
Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration.
Hospital Pharmacist 2003 ; 10: 354-361.
2900 ziar Hines S, Pleasance S.
Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration.
EJHP 2009 ; 15, 5: 32-38.
3374 ziar Smith R.P.R, Jones M.
Precipitation in Manchester: ketorolac/cyclizine
Anaesthesia 2001 ; 56: 494-495.
4982 Laborator Diamorphine Hydrochloride 100mg for Injection - Summary of Product Characteristics Updated 06-May-2020.
Wockhardt UK Ltd 2020
5073 Laborator Palladone 10 mg/ml solution for injection or infusion - Summary of Product Characteristics Updated 28-Apr-2025.
Napp Pharmaceuticals Limited 2025

  Mentions Légales